[Asia Economy Reporter Hwang Yoon-joo] Hugel announced on the 16th that it has obtained Canadian product approval from Health Canada for Botulax (export name Letybo) 50 units and 100 units.
The company stated, "We expect this to contribute to full-scale entry into the local market and expansion of overseas sales," and added, "We plan to carry out marketing activities by establishing sales strategies tailored to the characteristics of the local market."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

